GCTS vs NVDA

GCTS exhibits critical financial distress, highlighted by a Piotroski F-Score of 1/9 and a catastrophic Current Ratio of 0.15, indicating a severe liquidity crisis. The company is operating with negative gross margins (-63.40%) and collapsing revenue growth (-57.50% YoY), suggesting a fundamental failure in its business model. With a negative Price-to-Book ratio (-0.94), the company has effectively wiped out its equity. Despite a 'strong_buy' analyst consensus, the deterministic data points toward a high risk of insolvency.

NVDA exhibits strong financial health with a Piotroski F-Score of 7/9, indicating robust operational efficiency and solvency. While the current price of $182.08 is significantly above the Graham Number ($26.71) and the growth-based intrinsic value ($144.55), the stock is fundamentally undervalued relative to its growth, as evidenced by a PEG ratio of 0.72 and a highly attractive Forward P/E of 16.38. The company's elite profitability margins (55.6% profit margin) and minimal debt (0.07 D/E) provide a massive cushion for volatility. Despite bearish insider sentiment and short-term technical weakness, the long-term growth trajectory remains exceptionally strong.